Dr Iain Thomas

Dr Iain Thomas - Head of Life Sciences

Iain is Head of Life Sciences at Cambridge Enterprise, responsible for a team that is working across the life sciences sector from human health therapeutics to agritech and research tools.

Highlights from the team include acting as a founding partner for Apollo Therapeutics, a £40 million fund in early stage drug development, and the Ceres Agritech Knowledge Exchange Partnership. Spin-outs include X01 Therapeutics, Predictimmune Limited, PhoreMost, Z-factor and Cambridge Epigenetix. Iain also led discussions with GSK in respect of the University of Cambridge–GSK open innovation drug discovery initiative based at the Stevenage Bioscience Catalyst.

Previous experience includes time working at Plant Bioscience Limited (PBL) in technology transfer.

Iain has a PhD in Organic Chemistry and has nine academic papers published.

Iain joined Cambridge Enterprise in November 2003.